We are live on ! Find out more
VNRX icon

VolitionRx Ltd

31 hedge funds and large institutions have $4.52M invested in VolitionRx Ltd in 2026 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 10 increasing their positions, 1 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

900% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 1

50% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 8

11% more funds holding

Funds holding: 2831 (+3)

9% more capital invested

Capital invested by funds: $4.13M → $4.52M (+$392K)

0.17% more ownership

Funds ownership: 0.66%0.83% (+0.17%)

Holders
31
Holders Change
+3
Holders Change %
+10.71%
% of All Funds
0.38%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
12
Increased
10
Reduced
1
Closed
8
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Citigroup
26
Citigroup
New York
$1.76K +$2.08K +436 New
HPBT
27
Hickory Point Bank & Trust
Illinois
$1.01K +$1.19K +250 New
SS
28
SBI Securities
Japan
$323 +$353 +74 +1,233%
Morgan Stanley
29
Morgan Stanley
New York
$126 -$10 -2 -6%
Osaic Holdings
30
Osaic Holdings
Arizona
$87
BNP Paribas Financial Markets
31
BNP Paribas Financial Markets
France
$54
Citadel Advisors
32
Citadel Advisors
Florida
-$42.9K -8,387 Closed
Squarepoint
33
Squarepoint
New York
-$34.4K -6,733 Closed
Jane Street
34
Jane Street
New York
-$28.5K -5,571 Closed
VF
35
Virtu Financial
New York
-$28K -5,429 Closed
WAM
36
Warberg Asset Management
Illinois
-$23.2K -4,542 Closed
Susquehanna International Group
37
Susquehanna International Group
Pennsylvania
-$14.5K -2,842 Closed
Renaissance Technologies
38
Renaissance Technologies
New York
-$6.47K -1,265 Closed
Bank of America
39
Bank of America
North Carolina
-$245 -48 Closed

VNRX Hedge Fund Activity: Q1 2026 in Review

31 of the 8,128 institutional investors tracked by Wall St. Rank reported a position in VolitionRx Ltd (VNRX) for Q1 2026, worth a combined $4.52M — up 9.5% from $4.13M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new VNRX positions and 8 closed out — a net gain of 4 holders — while 10 added to existing stakes and 1 trimmed.

The largest buyer was Lagoda Investment Management, adding an estimated $1.12M. The largest seller was Citadel Advisors, exiting entirely with an estimated $42.9K sold.

  • 31 institutional investors held VolitionRx Ltd (VNRX) as of Q1 2026, up from 28 in Q4 2025.
  • Funds reported $4.52M of VolitionRx Ltd stock for Q1 2026, up 9.5% quarter-over-quarter.
  • 12 funds opened new VolitionRx Ltd positions in Q1 2026 and 8 closed out, a net change of +4 holders.
  • The largest VolitionRx Ltd buyer in Q1 2026 was Lagoda Investment Management, an estimated $1.12M added.
  • The largest VolitionRx Ltd seller in Q1 2026 was Citadel Advisors, an estimated $42.9K sold.

Based on aggregated 13F filings for Q1 2026.